Although patients receiving donepezil had higher expenditures for prescription drugs, a nonsignificant trend toward a reduced rate of institutionalization (10% placebo vs 5% donepezil) offset the effects increased drug costs.
← all excerpts
Cost-effectiveness of drug therapies for Alzheimer's disease: A brief review.
1
—
—